Title:
A renal function holding method which uses Xanthine redox enzyme inhibitor
Document Type and Number:
Japanese Patent JP6233899
Kind Code:
B2
Abstract:
The present invention relates to methods of preserving renal function in a subject in need thereof by administering a therapeutically effective amount of at least one xanthine oxidoreductase inhibiting compound or salt thereof.
More Like This:
| JP2002521408 | [Title of Invention] Compounds and Methods |
| WO/2003/002596 | USE OF DIPEPTIDYL PEPTIDASE IV INHIBITORS AS THERAPEUTICS FOR NEUROLOGICAL DISORDERS |
| JPS52144669 | 122AZAPROSTANIC ACID |
Inventors:
Christopher Rade Matzhar
Patricia McDonald
Patricia McDonald
Application Number:
JP2016114133A
Publication Date:
November 22, 2017
Filing Date:
June 08, 2016
Export Citation:
Assignee:
Takeda Pharmaceuticals U.S.A. Inc.
International Classes:
A61K31/426; A61P13/12; A61P19/02; A61P19/06
Foreign References:
| WO1992009279A1 |
Other References:
Arthritis & Rheumatism,2005年,52(3),p.916-923
日本痛風・核酸代謝学会総会プログラム・抄録集,2005年,38th,p.68
日本痛風・核酸代謝学会総会プログラム・抄録集,2005年,38th,p.68
Attorney, Agent or Firm:
Katsuma Osaki
Chihiro Watanabe
Chihiro Watanabe